— All Articles —
The latest from The Peptide Brief.
NHS Mounjaro Eligibility Expanded: More UK Patients Can Now Access Tirzepatide on the NHS
The NHS has broadened who can receive Mounjaro on prescription, with new rules now covering patients with a BMI of…
Retatrutide Phase 3 Results: The Weight Loss Jab That Beats Surgery — But You Cannot Get It Yet
New trial data shows retatrutide helped people lose nearly a third of their body weight on average — results that…
MHRA Pancreatitis Warning: What Every Mounjaro and Ozempic User in the UK Must Know
The UK medicines regulator has updated its official safety guidance for Mounjaro, Ozempic and similar weight loss jabs, flagging a…
Mounjaro and Ozempic users face fines for driving with side effects
Thousands of UK women taking weight loss jabs may not realise they could be breaking the law behind the wheel…
MHRA Pancreatitis Warning: What Every Woman on Mounjaro or Ozempic Needs to Know
The UK medicines regulator has updated its official safety guidance for Mounjaro and Ozempic, flagging a rare but serious risk…
Retatrutide Phase 3 Results: New Weight Loss Jab Outperforms Mounjaro in Landmark Trial
A new injectable weight loss treatment called retatrutide has produced results that have genuinely surprised researchers. In a major Phase…
Retatrutide Weight Loss Results: The Triple Hormone Jab That Beats Surgery
New phase 3 trial results show a drug called retatrutide helped people lose more weight than any medicine ever tested…
Mounjaro on the NHS: What the New GP Contract Really Means for You
From April 2026, GPs in England can prescribe Mounjaro for obesity as part of their NHS contract for the first…
Mounjaro NHS Rollout: The May 2026 Supply Deal That Could Change Everything
NHS England has struck a new supply agreement with Eli Lilly that could dramatically expand access to Mounjaro on the…